Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy

  • Home / Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy

Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy

New treatment options are needed to maintain and improve therapy for tuberculosis, which caused the death of 1.5 million people in 2013 despite potential for an 86 % treatment success rate. A greater understan…

About Post Author

Medical CPD & News

The Digitalis CPD trawler searches the web for all the latest news and journals.

Privacy Preference Center

Close your account?

Your account will be closed and all data will be permanently deleted and cannot be recovered. Are you sure?

Are you sure?

By disagreeing you will no longer have access to our site and will be logged out.